HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants.

AbstractBACKGROUND:
Dietary antioxidants with yet unproven efficacies in averting prostate cancer (PCa) are widely used in the United States as preventives. Experimental evidence establishing a causal relationship between oxidative and nitrosative stress (OS/NS) and PCa development and showing its modulation by dietary antioxidants would help justify their usage.
METHODS:
The TRAMP (Transgenic Adenocarcinoma of the Mouse Prostate) mouse model was used to demonstrate the OS/NS-associated damage, as evident by 8-hydroxy-2'-deoxyguanosine (8-OHdG), 4-hydroxynonenal (4-HNE)-protein-adducts and nitrotyrosine (Ntyr), in prostatic premalignant lesions, and to evaluate the antioxidant efficacy of various dietary supplements [natural antioxidant (NAO) from spinach extracts, (-) epigallocatechin-3-gallate (EGCG), or N-acetylcystein (NAC)] during the early PCa development.
RESULT:
We show, for the first time, that oxidative/nitrosative damages of genomic DNA and cellular proteins were discretely localized in premalignant lesions, but not in adjacent morphologically normal epithelia, of TRAMP prostates; these injuries were absent in age-matched nontransgenic littermates. The extent of OS/NS-related injuries correlated well with the tempo of development and prevalence of premalignant lesions in various prostatic lobes and exhibited a clear trend of increase from 12 to 20 weeks of age. Treatment of TRAMP mice with various antioxidants as dietary supplements resulted in differential alleviation of OS/NS-related prostatic injuries. The antioxidant potencies of the dietary supplements did not fully correlate with their documented antiPCa actions, suggest that they may exert additional "nonantioxidant," antitumor effects in this model.
CONCLUSIONS:
Our data indicate that in TRAMP mice, OS/NS injuries are likely involved in early prostatic tumorigenesis and can be modulated by various antioxidants.
AuthorsNeville N C Tam, Abraham Nyska, Robert R Maronpot, Grace Kissling, Liat Lomnitski, Andrew Suttie, Shlomo Bakshi, Margalit Bergman, Shlomo Grossman, Shuk-Mei Ho
JournalThe Prostate (Prostate) Vol. 66 Issue 1 Pg. 57-69 (Jan 01 2006) ISSN: 0270-4137 [Print] United States
PMID16114064 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright (c) 2005 Wiley-Liss, Inc.
Chemical References
  • Anticarcinogenic Agents
  • Antioxidants
  • Plant Extracts
Topics
  • Adenocarcinoma (pathology, prevention & control)
  • Administration, Oral
  • Animals
  • Anticarcinogenic Agents (administration & dosage, therapeutic use)
  • Antioxidants (administration & dosage, therapeutic use)
  • Diet
  • Male
  • Mice
  • Mice, Transgenic
  • Oxygen Consumption
  • Phytotherapy
  • Plant Extracts (therapeutic use)
  • Prostatic Neoplasms (pathology, prevention & control)
  • Spinacia oleracea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: